

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Levobupivacaine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Labor Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 20, 2024
Lead Product(s) : Levobupivacaine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hernia, Inguinal.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 31, 2022
Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hernia, Inguinal.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 29, 2022
Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Fresenius Kabi AB Brunna
Deal Size : Inapplicable
Deal Type : Inapplicable
MORphine Use in the Fascia Iliaca Compartment Block With UltraSound
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 19, 2019
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Fresenius Kabi AB Brunna
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levobupivacaine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
LaGRA Trial in Laparoscopic Cholecystectomy
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gallstones.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 09, 2018
Lead Product(s) : Levobupivacaine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levobupivacaine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Admescope
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Rectal Sheath Analgesia After Midline Laparotomy
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of General Surgery.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 17, 2016
Lead Product(s) : Levobupivacaine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Admescope
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Newco Trials Pesquisa Científica Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase III, Evaluate Noninferiority Between Levobupivacaine and Bupivacaine in Spinal Anesthesia.
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Spinal Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 26, 2013
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Newco Trials Pesquisa Científica Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levobupivacaine
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Infusion of a Local Anaesthetic in the Surgical After Modified Radical Mastectomy With Expander
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 08, 2011
Lead Product(s) : Levobupivacaine
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
